Precigen (PGEN) Cost of Revenue: 2013-2025

Historic Cost of Revenue for Precigen (PGEN) over the last 12 years, with Sep 2025 value amounting to $1.0 million.

  • Precigen's Cost of Revenue rose 2.58% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 1.35%. This contributed to the annual value of $4.3 million for FY2024, which is 30.27% down from last year.
  • According to the latest figures from Q3 2025, Precigen's Cost of Revenue is $1.0 million, which was down 5.22% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Precigen's Cost of Revenue peaked at $7.4 million during Q1 2021, and registered a low of $914,000 during Q2 2021.
  • Over the past 3 years, Precigen's median Cost of Revenue value was $1.1 million (recorded in 2025), while the average stood at $1.2 million.
  • Examining YoY changes over the last 5 years, Precigen's Cost of Revenue showed a top increase of 117.87% in 2021 and a maximum decrease of 88.77% in 2021.
  • Quarterly analysis of 5 years shows Precigen's Cost of Revenue stood at $2.9 million in 2021, then slumped by 56.46% to $1.3 million in 2022, then climbed by 8.04% to $1.4 million in 2023, then decreased by 13.92% to $1.2 million in 2024, then climbed by 2.58% to $1.0 million in 2025.
  • Its Cost of Revenue stands at $1.0 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.1 million for Q1 2025.